AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...

The boss of drugmaker AstraZeneca has said he was “very disappointed” with the firm’s move to scrap plans for a £450 million ...

AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Whitehall editor Kate Devlin question why ...

AstraZeneca scrapped plans for a £450 million UK vaccine plant after rejecting a £78 million government offer, citing ...

AstraZeneca has halted plans to build a £450 million vaccine plant in the UK due to decreased government support, prompting ...

Pascal Soriot, chief executive of AstraZeneca, denied any rift with the Government over the decision, which it revealed ...

The boss of drugmaker AstraZeneca has said he was ‘very disappointed’ with the firm’s move to scrap plans for a £450 million vaccine plant in Liverpool, but insisted the business case did ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. We get into more ...

The pharmaceutical giant announced its decision to cancel its planned investment just two days after Chancellor Rachel Reeves ...

Unlike GSK which delivered a lopsided performance thanks to weakness in its vaccines arm, AstraZeneca looks more balanced with gains recorded across all therapy areas. “So far, so good ...

AstraZeneca said it was "disappointed" that the investment had not worked out The plan to expand the site, which manufactures the flu vaccine, was announced by then-chancellor Jeremy Hunt in the ...